Professor Mathieu, you have been awarded this year's Distinguished International Service in the Cause of Diabetes Prize of the ADA. Congratulations! The award honours individuals who have demonstrated outstanding research like you have. And many of these aspects were covered in your award lecture. Can you give us some key points about that? What I try to explain in my award lecture is that I'm actually a dinosaur, still combining basic research, and clinical research together with clinical care. and clinical research together with clinical care. And I didn't have time to explain my basic research, which is really focused on understanding better the pathophysiology of type 1 diabetes, and also coming towards a cure, a prevention for type 1 diabetes. But I mainly talked about the clinical research that I helped coordinate throughout Europe with intervention trials using disease-modifying therapies in type 1 diabetes. Because these are my goals in life: to improve care for those living with diabetes, but secretly my big goal is to help find a prevention and a cure for type 1 diabetes. Are there any other goals that you try to achieve in the next years? What I try to do is to prevent people from reinventing the wheel, and work together in all aspects. And here, for instance, comes now the European Diabetes Forum, where EASD created, several years ago, this platform where we come together with different societies like IDF Europe, and ISPAD, and Société Francophone du Diabète, PCDE, but also with industry. And coming together to really discuss about important policy topics and bring, in a harmony of voices, a message to the policymakers, so that we can change the way care is brought to people with diabetes, but also the way, for instance, research is supported and really to advance this field of diabetes. And looking back on your career, what has driven you both as a researcher and also as a science manager also President of the European Association for the Study of Diabetes? What drives me day-to-day is stories of patients. I was offered frequently the possibility to go into administration, or to go into more basic research, and not see patients anymore, and I always refused it. Because I get so much from my contacts with the patients. They really inspire me, they drive me in everything I do. And it's patient stories that really motivate me to talk to my peers, and really bring everybody together, and collaborate in basic research, and also in clinical research. Hence the title of my talk, Unity Makes Strength. That's great, and thank you very much. And long live EASD. Yes!